Global Respiratory Inhalers Market to Grow at a CAGR of 5.4% During 2024-2032, Aided by the Increasing Prevalence of Respiratory Diseases Across the Globe

Global Respiratory Inhalers Market Overview

A respiratory inhaler is a small, handheld medical device that enables the delivery of medication directly to the lungs of the patient. Dry powder, soft mist inhalers, and metered-dose are some of the common types of respiratory inhalers available in the market. The rising burden of respiratory disorders and the advancements in inhaler devices are driving the growth of the market. The shift towards environmentally friendly inhalers that have a lower carbon footprint is a significant trend poised to impact the market dynamics. Moreover, the rising introduction of smart inhalers that enhance patient adherence and the growing emphasis on improving inhaler design are likely to influence the market growth in the forecast period.

Key Findings 

• Chronic obstructive pulmonary disease (COPD) and asthma pose a major public health problem. The overall prevalence of chronic obstructive pulmonary disease is estimated to be 12.64% in individuals aged 40 years and above. The high prevalence of respiratory disorders is one of the primary factors fuelling the market growth. 
• In April 2024, Adherium's Hailie Smartinhaler platform (a cloud-based solution leveraging Bluetooth-enabled sensors) for use with AstraZeneca's asthma and chronic obstructive pulmonary disease (COPD) inhalers was approved by the US Food and Drug Administration (FDA) to improve patient monitoring and adherence along with facilitating personalized treatments. The growth in the number of such regulatory approvals is set to support market expansion.
• The increasing improvements in healthcare services and the rise in favorable government policies and health insurance coverage for respiratory conditions are expected to elevate the market value in the forecast period.

Global Respiratory Inhalers Market Demand Drivers

Recent data reveals that asthma is one of the most common and expensive diseases in the United States, with every 1 in 12 people affected by this respiratory condition. It is estimated that more than 27 million individuals in the United States are living with asthma. Further, asthma is reported as a leading chronic disease in children, affecting around 4.5 million children under the age of 18 years. The increasing cases of asthma and other respiratory disorders are a major market driver, contributing to the rise in the demand for respiratory inhalers.

Global Respiratory Inhalers Market Segmentation Analysis

Product Segment Represents a Significant Market Share

Based on the product, the market segmentation includes dry powder inhalers, metered dosed inhalers, soft mist inhalers, nebulizers, and jet nebulizers (ultrasonic nebulizers, and mesh nebulizers). Dry powder inhalers are breath-activated and thus release medication in a powdered form when inhaled by the patient. They generate a significant demand among asthma and chronic pulmonary obstructive disease patients due to their ease of use. The metered dose inhalers segment also holds a high market value as they are generally more affordable than other inhaler types. In addition, the well-established production and distribution networks of metered dose inhalers further support the growth of the segment.

The market report also offers insights based on type, indication, end user, and region.

Global Respiratory Inhalers Market: Competitive Landscape

• In September 2024, the leading British-Swedish biopharma firm AstraZeneca announced the completion of its clinical program that involved the transition of its respiratory medicine delivered in pressurized metered-dose inhalers to a new low-carbon propellant that has a 99.9% lower Global Warming Potential (GWP) compared to the current standard of propellants.
• In September 2023, Kindeva Drug Delivery, a global contract development and manufacturing organization specializing in drug-device combination products, secured a grant worth Euro 33 million from the U.K. Government’s Life Sciences Innovation Manufacturing Fund (LSIMF) to boost the development and manufacturing of the next generation of green pressurized metered-dose inhalers.
• Other players involved in the market include Novartis AG, GSK plc, Chiesi Farmaceutici SpA, Lupin, Teva Pharmaceutical Industries Ltd, OMRON Corporation, Koninklijke Philips N.V., PARI GmbH, Boehringer Ingelheim International GmbH, GLENMARK PHARMACEUTICALS LTD, Presspart Verwaltungs GmbH, Rossmax International Ltd, HELTMAN Medikal A.S., and Microlife Corporation.

Global Respiratory Inhalers Market Analysis by Region

North America is Anticipated to Lead the Market Share 

The market report offers an insight into various geographical locations, including North America, Europe, Asia Pacific, Latin America along with Middle East and Africa. North America dominates the market share due to the high prevalence rates of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related conditions in the region. The presence of an advanced healthcare system and heightened awareness about respiratory health further support market growth. Moreover, the increasing population and favorable government initiatives are poised to bolster the market expansion in the region in the forecast period.

Key Offerings of the Report

• The EMR report gives an overview of the global market for respiratory inhalers for the time span of (2017-2023) and (2024-2032).
• The report also offers historical (2017-2023) and forecast (2024-2032) market information for the product, type, indication, end-user, and region of the global market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790